{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:07:43Z","timestamp":1788995263644,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejps.2026.107633","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T14:58:02Z","timestamp":1786805882000},"page":"107633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery of a Potent and Selective KRAS G12D Degrader based on PROTAC Degradation"],"prefix":"10.1016","volume":"226","author":[{"given":"Lili","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangjian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangjiang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youlu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6120","key":"10.1016\/j.ejps.2026.107633_bib0003","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/327293a0","article-title":"Prevalence of ras gene mutations in human colorectal cancers [J]","volume":"327","author":"BOS","year":"1987","journal-title":"Nature"},{"issue":"7781","key":"10.1016\/j.ejps.2026.107633_bib0007","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41586-019-1694-1","article-title":"The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity [J]","volume":"575","author":"CANON","year":"2019","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.ejps.2026.107633_bib0027","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/s41589-019-0362-y","article-title":"Development of targeted protein degradation therapeutics [J]","volume":"15","author":"CHAMBERLAIN","year":"2019","journal-title":"Nature chemical biology"},{"key":"10.1016\/j.ejps.2026.107633_bib0023","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.bioorg.2018.09.005","article-title":"Chemically induced degradation of CK2 by proteolysis targeting chimeras based on a ubiquitin-proteasome pathway [J]","volume":"81","author":"CHEN","year":"2018","journal-title":"Bioorg Chem"},{"issue":"8","key":"10.1016\/j.ejps.2026.107633_bib0031","doi-asserted-by":"crossref","first-page":"8010","DOI":"10.1021\/acs.jmedchem.4c02438","article-title":"Auto-RapTAC: A Versatile and Sustainable Platform for the Automated Rapid Synthesis and Evaluation of PROTAC [J]","volume":"68","author":"CHEN","year":"2025","journal-title":"J Med Chem"},{"issue":"4","key":"10.1016\/j.ejps.2026.107633_bib0015","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41571-023-00736-3","article-title":"Protein degraders enter the clinic - a new approach to cancer therapy [J]","volume":"20","author":"CHIRNOMAS","year":"2023","journal-title":"Nature reviews Clinical oncology"},{"issue":"11","key":"10.1016\/j.ejps.2026.107633_bib0001","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nrd4389","article-title":"Drugging the undruggable RAS: Mission possible? [J]","volume":"13","author":"COX","year":"2014","journal-title":"Nature reviews Drug discovery"},{"issue":"18","key":"10.1016\/j.ejps.2026.107633_bib0013","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1158\/0008-5472.CAN-23-1313","article-title":"Dual Inhibition of KRASG12D and Pan-ERBB Is Synergistic in Pancreatic Ductal Adenocarcinoma [J]","volume":"83","author":"GULAY","year":"2023","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.ejps.2026.107633_bib0011","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1038\/s41591-022-02007-7","article-title":"Anti-tumor efficacy of a potent and selective non-covalent KRAS(G12D) inhibitor [J]","volume":"28","author":"HALLIN","year":"2022","journal-title":"Nature medicine"},{"issue":"10","key":"10.1016\/j.ejps.2026.107633_bib0017","doi-asserted-by":"crossref","first-page":"10238","DOI":"10.1021\/acs.jmedchem.5c00428","article-title":"Discovery and Characterization of RP03707: A Highly Potent and Selective KRAS(G12D) PROTAC [J]","volume":"68","author":"JI","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.ejps.2026.107633_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2023.1098331","article-title":"E3 ligase ligand optimization of Clinical PROTACs [J]","volume":"11","author":"JIANG","year":"2023","journal-title":"Frontiers in chemistry"},{"issue":"11","key":"10.1016\/j.ejps.2026.107633_bib0022","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5","article-title":"Click Chemistry: Diverse Chemical Function from a Few Good Reactions [J]","volume":"40","author":"KOLB","year":"2001","journal-title":"Angewandte Chemie (International ed in English)"},{"issue":"5","key":"10.1016\/j.ejps.2026.107633_bib0004","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.apsb.2019.03.002","article-title":"Targeting the untargetable KRAS in cancer therapy [J]","volume":"9","author":"LIU","year":"2019","journal-title":"Acta Pharm Sin B"},{"issue":"Pt 2","key":"10.1016\/j.ejps.2026.107633_bib0028","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.semcancer.2020.02.006","article-title":"PROTACs: A novel strategy for cancer therapy [J]","volume":"67","author":"LIU","year":"2020","journal-title":"Seminars in cancer biology"},{"issue":"19","key":"10.1016\/j.ejps.2026.107633_bib0019","doi-asserted-by":"crossref","first-page":"20103","DOI":"10.1021\/acs.jmedchem.5c01034","article-title":"ZJK-807: A Selective PROTAC Degrader of KRAS(G12D) Overcoming Resistance in Pancreatic Cancer [J]","volume":"68","author":"LIU","year":"2025","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.ejps.2026.107633_bib0029","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12943-022-01535-7","article-title":"Clinical considerations for the design of PROTACs in cancer [J]","volume":"21","author":"NIETO-JIM\u00e9NEZ","year":"2022","journal-title":"Molecular cancer"},{"issue":"11","key":"10.1016\/j.ejps.2026.107633_bib0005","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd.2016.139","article-title":"Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design [J]","volume":"15","author":"OSTREM","year":"2016","journal-title":"Nature reviews Drug discovery"},{"issue":"1","key":"10.1016\/j.ejps.2026.107633_bib0008","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cell.2017.06.009","article-title":"RAS Proteins and Their Regulators in Human Disease [J]","volume":"170","author":"SIMANSHU","year":"2017","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ejps.2026.107633_bib0020","doi-asserted-by":"crossref","first-page":"273","DOI":"10.37349\/etat.2020.00018","article-title":"Current strategies for the design of PROTAC linkers: a critical review [J]","volume":"1","author":"TROUP","year":"2020","journal-title":"Exploration of targeted anti-tumor therapy"},{"key":"10.1016\/j.ejps.2026.107633_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102070","article-title":"From undruggable to a druggable Cancer Target [J]","volume":"89","author":"UPRETY","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ejps.2026.107633_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113749","article-title":"Developments of CRBN-based PROTACs as potential therapeutic agents [J]","volume":"225","author":"WANG","year":"2021","journal-title":"Eur J Med Chem"},{"issue":"4","key":"10.1016\/j.ejps.2026.107633_bib0010","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1021\/acs.jmedchem.1c01688","article-title":"Identification of MRTX1133, a Noncovalent, Potent, and Selective KRAS(G12D) Inhibitor [J]","volume":"65","author":"WANG","year":"2022","journal-title":"J Med Chem"},{"issue":"22","key":"10.1016\/j.ejps.2026.107633_bib0021","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.4155\/fmc-2019-0159","article-title":"Triazol: a privileged scaffold for proteolysis targeting chimeras [J]","volume":"11","author":"XIA","year":"2019","journal-title":"Future medicinal chemistry"},{"issue":"14","key":"10.1016\/j.ejps.2026.107633_bib0024","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.bmcl.2018.05.057","article-title":"Development of the first small molecule histone deacetylase 6 (HDAC6) degraders [J]","volume":"28","author":"YANG","year":"2018","journal-title":"Bioorganic & medicinal chemistry letters"},{"issue":"3","key":"10.1016\/j.ejps.2026.107633_bib0002","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","article-title":"Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism [J]","volume":"149","author":"YING","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejps.2026.107633_bib0016","doi-asserted-by":"crossref","unstructured":"YOSHINARI T, NAGASHIMA T, ISHIOKA H, et al. Discovery of KRAS(G12D) selective degrader ASP3082 [J]. Commun Chem, 2025, 8(1): 254.","DOI":"10.1038\/s42004-025-01662-4"},{"key":"10.1016\/j.ejps.2026.107633_bib0012","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.canlet.2018.05.042","article-title":"A CRISPR-Cas13a system for efficient and specific therapeutic targeting of mutant KRAS for pancreatic cancer treatment [J]","volume":"431","author":"ZHAO","year":"2018","journal-title":"Cancer letters"},{"issue":"1","key":"10.1016\/j.ejps.2026.107633_bib0014","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41392-022-00966-4","article-title":"Targeted protein degradation: mechanisms, strategies and application [J]","volume":"7","author":"ZHAO","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ejps.2026.107633_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.112028","article-title":"Design and synthesis of \u03b1-naphthoflavone chimera derivatives able to eliminate cytochrome P450 (CYP)1B1-mediated drug resistance via targeted CYP1B1 degradation [J]","volume":"189","author":"ZHOU","year":"2020","journal-title":"Eur J Med Chem"},{"issue":"7","key":"10.1016\/j.ejps.2026.107633_bib0009","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.ccell.2024.06.001","article-title":"Anti-tumor efficacy of HRS-4642 and its potential combination with proteasome inhibition in KRAS G12D-mutant cancer [J]","volume":"42","author":"ZHOU","year":"2024","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.ejps.2026.107633_bib0018","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1021\/acs.jmedchem.3c01622","article-title":"Design, Synthesis, and Biological Evaluation of Potent and Selective PROTAC Degraders of Oncogenic KRAS(G12D) [J]","volume":"67","author":"ZHOU","year":"2024","journal-title":"J Med Chem"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726002071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726002071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:38:10Z","timestamp":1788993490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098726002071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":31,"alternative-id":["S0928098726002071"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107633","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of a Potent and Selective KRAS G12D Degrader based on PROTAC Degradation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107633","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107633"}}